Infographic: Hybrid Closed-Loop Insulin Delivery Systems - Outcomes and Outlooks

Hybrid closed-loop insulin delivery systems, also called an “artificial pancreas,” have attracted a great deal of attention since the FDA approved the first such device last September. These systems continuously monitor blood glucose levels and adjust insulin dosing accordingly, although they require some input from users around mealtimes.

Supporters envision that these technologies could help more patients with diabetes optimally control their blood glucose, especially among younger populations that may find it more difficult to administer the right amount of insulin at the right time. At the 77^th Scientific Sessions of the American Diabetes Association, a symposium discussed progress towards the artificial pancreas, inviting experts to discuss perspectives from the European and US viewpoints. For more on the take-aways from this symposium, see the infographic below.